Table 2.
Parameter (Unit) | Week 1 | Week 3 | Week 15 | ||||||
---|---|---|---|---|---|---|---|---|---|
Control | RT | RT Los | Control | RT | RT Los | Control | RT | RT Los | |
White blood cell counts (109/L) | 5.79 ± 0.43 | 6.18 ± 0.7 | 7.15 ± 0.36 * | 4.44 ± 0.56 | 6.77 ± 0.8 * | 7.16 ± 0.7 * | 6.09 ± 0.58 | 6 ± 0.39 | 6.51 ± 0.52 |
Platelet counts (109/L) | 569 ± 8 | 587 ± 20 | 643 ± 33 | 559 ± 27 | 646 ± 35 | 673 ± 31 * | 636 ± 17 | 586 ± 67 | 736 ± 53 |
Red blood cell counts (1012/L) | 6.69 ± 0.11 | 7.37 ± 0.29 * | 7.74 ± 0.2 * | 7.54 ± 0.15 | 7.54 ± 0.18 | 7.95 ± 0.18 | 8.30 ± 0.15 | 9.16 ± 0.44 | 9.50 ± 0.3 * |
Hemoglobin (g/L) | 130 ± 3 | 143 ± 5 | 146 ± 3 * | 143 ± 3 | 142 ± 3 | 152 ± 3 | 146 ± 2 | 165 ± 8 * | 175 ± 7 * |
Hematocrit (L/L) | 0.41 ± 0.01 | 0.44 ± 0.02 | 0.45 ± 0.01 | 0.44 ± 0.01 | 0.45 ± 0.01 | 0.47 ± 0.01 | 0.43 ± 0.01 | 0.49 ± 0.02 * | 0.50 ± 0.02 * |
Values are presented as mean ± S.E.M., * p < 0.05 vs. control group, (n = 6–7, One-Way ANOVA, Holm-Sidak post hoc test). RT: radiotherapy only group (50 Gy), RT Los: RT plus losartan group.